HRP20120049T1 - Farmaceutski dozirni oblik koji obuhvaća pilule kao i postupak njegove proizvodnje - Google Patents

Farmaceutski dozirni oblik koji obuhvaća pilule kao i postupak njegove proizvodnje Download PDF

Info

Publication number
HRP20120049T1
HRP20120049T1 HR20120049T HRP20120049T HRP20120049T1 HR P20120049 T1 HRP20120049 T1 HR P20120049T1 HR 20120049 T HR20120049 T HR 20120049T HR P20120049 T HRP20120049 T HR P20120049T HR P20120049 T1 HRP20120049 T1 HR P20120049T1
Authority
HR
Croatia
Prior art keywords
dosage form
pill
pantoprazole
starch
form according
Prior art date
Application number
HR20120049T
Other languages
English (en)
Croatian (hr)
Inventor
Anstett-Klein Isabel
Schiller Marc
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of HRP20120049T1 publication Critical patent/HRP20120049T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20120049T 2004-05-07 2005-05-04 Farmaceutski dozirni oblik koji obuhvaća pilule kao i postupak njegove proizvodnje HRP20120049T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04101982 2004-05-07
PCT/EP2005/052066 WO2005107721A2 (fr) 2004-05-07 2005-05-04 Forme galenique pharmaceutique et procede de fabrication de celle-ci

Publications (1)

Publication Number Publication Date
HRP20120049T1 true HRP20120049T1 (hr) 2012-02-29

Family

ID=34929072

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120049T HRP20120049T1 (hr) 2004-05-07 2005-05-04 Farmaceutski dozirni oblik koji obuhvaća pilule kao i postupak njegove proizvodnje

Country Status (15)

Country Link
US (1) US20070231388A1 (fr)
EP (1) EP1746980B1 (fr)
JP (1) JP2007536349A (fr)
AT (1) ATE531361T1 (fr)
AU (1) AU2005239838B2 (fr)
CA (1) CA2565083C (fr)
CY (1) CY1112256T1 (fr)
DK (1) DK1746980T3 (fr)
ES (1) ES2376466T3 (fr)
HR (1) HRP20120049T1 (fr)
PL (1) PL1746980T3 (fr)
PT (1) PT1746980E (fr)
RS (1) RS52233B (fr)
SI (1) SI1746980T1 (fr)
WO (1) WO2005107721A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
EP2061440A2 (fr) 2007-04-04 2009-05-27 Sigmoid Pharma Limited Composition pharmaceutique à base de tacrolimus
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (fr) 2011-01-28 2012-08-02 Zx Pharma, Llc Composition de mélatonine à libération contrôlée et procédés associés
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
TR201808978T4 (tr) 2011-02-11 2018-07-23 Zx Pharma Llc Çok partiküllü l-mentol formülasyonları ve ilgili yöntemler.
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
EP2988824B1 (fr) * 2013-04-23 2018-11-07 Zx Pharma, Llc Composition entérique multiparticulaire revêtue à sous-revêtement protéique
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
CN104382881A (zh) * 2014-11-20 2015-03-04 哈尔滨圣吉药业股份有限公司 一种甲砜霉素肠溶微丸及其制备方法
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7212484B2 (ja) * 2017-09-20 2023-01-25 大原薬品工業株式会社 腸溶性被覆顆粒の耐酸性が改善された圧縮成形製剤の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US5433959A (en) 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
ES2032394T3 (es) * 1986-02-20 1993-02-16 Hoechst Aktiengesellschaft Procedimiento para preparar derivados de tienoimidazol sustituidos.
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
CA1256109A (fr) * 1986-09-10 1989-06-20 Franz Rovenszky Methode de preparation de derives de 4,5-dihydro- oxazoles
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
IL85472A (en) 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3901151A1 (de) 1989-01-17 1990-07-19 Hoechst Ag Stabile pharmazeutische zubereitungen von thienoimidazol-derivaten und deren orale anwendung als magensaeuresekretionshemmer
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
DE4322572A1 (de) 1993-07-07 1995-01-12 Byk Gulden Lomberg Chem Fab Beutelverpackung für flüssige Arzneimittel
ES2094694B1 (es) 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
GB9710800D0 (en) 1997-05-23 1997-07-23 Cipla Limited Pharmaceutical composition and method of preparing it
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
DK173431B1 (da) * 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
DE69925740T2 (de) * 1999-12-16 2006-05-11 Laboratorio Medinfar-Produtos Farmacéuticos, S. A. Neue stabile mehreinheitliche substituierte Benzimidazole enthaltende pharmazeutische Präparate
US6346269B1 (en) 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo

Also Published As

Publication number Publication date
US20070231388A1 (en) 2007-10-04
EP1746980B1 (fr) 2011-11-02
CY1112256T1 (el) 2015-12-09
CA2565083A1 (fr) 2005-11-17
JP2007536349A (ja) 2007-12-13
DK1746980T3 (da) 2012-01-30
AU2005239838A1 (en) 2005-11-17
SI1746980T1 (sl) 2012-03-30
PT1746980E (pt) 2012-01-25
WO2005107721A2 (fr) 2005-11-17
PL1746980T3 (pl) 2012-03-30
CA2565083C (fr) 2014-07-08
ES2376466T3 (es) 2012-03-14
EP1746980A2 (fr) 2007-01-31
AU2005239838B2 (en) 2011-08-11
ATE531361T1 (de) 2011-11-15
RS52233B (sr) 2012-10-31
WO2005107721A3 (fr) 2006-07-20

Similar Documents

Publication Publication Date Title
AU2007234398B9 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
US6787155B2 (en) Anti-inflammatory pharmaceutical formulations
RU2089180C1 (ru) Орально вводимая форма лекарственного средства на основе пантопразола
JP3699122B2 (ja) 新規な経口用の医薬使用形態
US6174548B1 (en) Omeprazole formulation
US9532945B2 (en) Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
US20040028735A1 (en) Pharmaceutical formulation
US6733778B1 (en) Omeprazole formulation
ZA200609541B (en) Coated tablet formulation and method
KR20090091083A (ko) 방출성이 제어된 심혈관계질환 치료용 약제학적 제제
KR101164300B1 (ko) 약제학적 제제
JP2011126912A (ja) 活性成分としてのパントプラゾールを含有する投与形
US20130216617A1 (en) Pharmaceutical compositions of (r)-lansoprazole
CA2565083C (fr) Nouvelle forme posologique pharmaceutique et procede de fabrication
US20090208575A1 (en) Pharmaceutical Composition Of Acid Labile Substances
KR20130103384A (ko) 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
SI22849A (sl) Ropinirolni pripravek
CA2654525A1 (fr) Compositions pharmaceutiques comprenant une combinaison de piperidinoalcanol et d'un decongestionnant
JP6096328B2 (ja) 口腔内崩壊錠
US20020090395A1 (en) Anti-inflammatory pharmaceutical formulations
CN104434872A (zh) 一种稳定的盐酸度洛西汀肠溶胶囊及其制备方法
JPWO2015046383A1 (ja) 原薬含有核の製造方法、原薬含有核、医薬品組成物、及び口腔内崩壊錠
KR20130020740A (ko) 둘록세틴 또는 이의 약학적으로 허용되는 염을 포함하는 지연 방출형 제제 및 이의 제조방법
KR101072600B1 (ko) 플루바스타틴을 포함하는 안정한 약제학적 조성물 및 그의 제조방법
US20100303920A1 (en) Aqueous Film Coating Composition / 841